4//SEC Filing
Ally Bridge MedAlpha Master Fund L.P. 4
Accession 0000899243-23-016125
CIK 0001402479other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:05 PM ET
Size
22.8 KB
Accession
0000899243-23-016125
Insider Transaction Report
Form 4
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
ABG Management Ltd.
10% Owner
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Yu Fan
10% Owner
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
ABG WTT-MedAvail Ltd
10% Owner
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Ally Bridge Group (NY) LLC
10% Owner
Transactions
- Other
Series A Warrant (Right to Buy)
2023-06-16+6,818,181→ 6,818,181 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (6,818,181 underlying) - Other
Series A Warrant (Right to Buy)
2023-06-16+965,130→ 965,130 total(indirect: See footnote)Exercise: $0.39From: 2023-06-16Exp: 2028-06-16→ Common Stock (965,130 underlying)
Footnotes (3)
- [F1]On March 13, 2023, pursuant to the securities purchase agreement, dated as of March 9, 2023 (the "2023 Securities Purchase Agreement"), by and among the Issuer and the certain purchasers listed therein, ABG WTT-MedAvail Limited ("ABG WTT") and Ally Bridge MedAlpha Master Fund L.P. ("MedAlpha") purchased from the Issuer 6,818,181 and 965,130 Pre-Funded Warrants, respectively, at a purchase price of $0.3212 per share. Pursuant to the 2023 Securities Purchase Agreement, ABG WTT and MedAlpha also purchased for no additional consideration 6,818,181 and 965,130 Series A Warrants, respectively. The Series A Warrants were issued two business days following the date the Issuer received required approval of the Issuer's stockholders on June 14, 2023.
- [F2]These securities are held of record by ABG WTT. ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership.
- [F3]These securities are held of record by MedAlpha. Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.
Documents
Issuer
MedAvail Holdings, Inc.
CIK 0001402479
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001831963
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:05 PM ET
- Size
- 22.8 KB